Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.

Outsource API manufacturing to India for lower costs, GMP-compliant quality, scalable production, and faster time-to-market for pharma companies.

Feb 23 (Reuters) - AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient ...

General Atlantic, KKR and CVC are among global PE firms evaluating a minority stake in IndiaRF-backed Synthimed, which is ...

Axplora invests $30 million in lyophilization at Le Mans site, boosting ADC production. Facilities enhance control, reliability, and traceability.

Just like algae blooms in the ocean and pollen in the spring, there’s been an explosion in the past year or two of new software, related tools and lingo from the IT and mainstream/consumer side. Some ...

MUSCAT, FEB 23As Oman advances its ambitions under Oman Vision 2040, the spotlight is increasingly shifting from mere ...

Sudarshan Pharma Industries Limited has announced that it has successfully obtained two significant international certifications for its manufacturing facility located in Hyderabad, Telangana. The ...

The Physical Foundation of Efficiency The realization of a smart factory begins with the physical capability to execute complex tasks without human intervention. CCIG has established its manufacturing ...

SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

Sudarshan Pharma Industries share price falls 3% after GST department launches search at Mumbai office; Q3FY26 profit rises ...

AI-powered RDS orchestration synchronizes AMRs and voice picking to deliver goods-to-person performance at a fraction ...